The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.
Open accessAbstract
The immunoglobulin kappa light chain gene contains a lymphoid-specific enhancer that includes several short protein-binding sequences. The sequence that binds the nuclear factor NF-kappa B was tested for its ability to act independently as an enhancer element by inserting it into test plasmids containing the chloramphenicol acetyltransferase gene. When analyzed for activity by transient transfection into lymphoid and nonlymphoid cells, a single copy of the NF-kappa B binding site could act as a tissue-specific upstream activating element. Two copies (dimer) showed 10-fold higher activity than did one copy and could act as an enhancer element 2.5 kilobases downstream of the transcriptional start site. The enhancer activity of this sequence was correlated with the presence of the cognate binding protein, NF-kappa B. This sequence acted as an inducible enhancer under conditions that induce NF-kappa B binding activity. Thus, the NF-kappa B binding site acts by itself as a tissue-specific and inducible enhancer element, and two copies show cooperative interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Self-citationAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Self-citationInducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Self-citationBiochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor
Wigler, M., Pellicer, A., Silverstein, S., & Axel, R. (1978) · Cell · doi:10.1016/0092-8674(78)90254-4 · Cited by 1,210
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
BOSHART, M., WEBER, F., JAHN, G., DORSCHHLER, K., FLECKENSTEIN, B., & SCHAFFNER, W. (1985) · Cell · doi:10.1016/s0092-8674(85)80025-8 · Cited by 1,140
B Lineage—Specific Interactions of an Immunoglobulin Enhancer with Cellular Factors in Vivo
Ephrussi, A., Church, G. M., Tonegawa, S., & Gilbert, W. (1985) · Science · doi:10.1126/science.3917574 · Cited by 796
Immunoglobulin gene transcription is activated by downstream sequence elements
Queen, C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90016-8 · Cited by 791
Self-citationProtein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility
Lenardo, M., Pierce, J. W., & Baltimore, D. (1987) · Science · doi:10.1126/science.3109035 · Cited by 578
Self-citation
Cited by
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Self-citationBaeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,166
Self-citationIMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Self-citationMcKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
Schmitz, M. L., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04950.x · Cited by 796
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano, M. B., & Leonard, W. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4328 · Cited by 657
Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., & Fiers, W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00542.x · Cited by 651
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
Brown, J. D., Lin, C. Y., Duan, Q., Griffin, G., Federation, A. J., Paranal, R. M., Bair, S., Newton, G., Lichtman, A. H., Kung, A. L., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.024 · Cited by 614
DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
Nolan, G. P., Ghosh, S., Liou, H.-C., Tempst, P., & Baltimore, D. (1991) · Cell · doi:10.1016/0092-8674(91)90320-x · Cited by 596
Self-citationMesser, G., Spengler, U., Jung, M. C., Honold, G., Blömer, K., Pape, G. R., Riethmüller, G., & Weiss, E. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.209 · Cited by 543
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Baeuerle, P. A., & Baltimore, D. (1989) · Genes & Development · doi:10.1101/gad.3.11.1689 · Cited by 505
Self-citationNuclear factor kappa B, a mediator of lipopolysaccharide effects
Müller, J. M., Ziegler-Heitbrock, H. W. L., & Baeuerle, P. A. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80342-6 · Cited by 475
Lenardo, M. J., Fan, C.-M., Maniatis, T., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90966-5 · Cited by 473
Self-citationActivation of Interleukin-6 Gene Expression through the NF-κB Transcription Factor
Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327-2334.1990 · Cited by 403
Self-citationBöhnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R., & Greene, W. C. (1988) · Cell · doi:10.1016/0092-8674(88)90099-2 · Cited by 400
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis.
Grimm, S., Bauer, M. K., Baeuerle, P. A., & Schulze-Osthoff, K. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.1.13 · Cited by 354
Seipel, K., Georgiev, O., & Schaffner, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05603.x · Cited by 349
Ruben, S., Poteat, H., Tan, T.-H., Kawakami, K., Roeder, R., Haseltine, W., & Rosen, C. A. (1988) · Science · doi:10.1126/science.2838905 · Cited by 321
Transactivation by AP-1 Is a Molecular Target of T Cell Clonal Anergy
Kang, S.-M., Beverly, B., Tran, A.-C., Brorson, K., Schwartz, R. H., & Lenardot, M. J. (1992) · Science · doi:10.1126/science.257.5073.1134 · Cited by 318
NF-κB Subunit Regulation in Nontransformed CD4 + T Lymphocytes
Kang, S.-M., Tran, A.-C., Grilli, M., & Lenardo, M. J. (1992) · Science · doi:10.1126/science.1604322 · Cited by 314
Self-citationVisvanathan, K. V., & Goodbourn, S. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03483.x · Cited by 303
Plevy, S. E., Gemberling, J. H. M., Hsu, S., Dorner, A. J., & Smale, S. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4572 · Cited by 302
Molecular Events Mediating T Cell Activation
Altman, A., Coggeshall, K. M., & Mustelin, T. (1990) · Advances in Immunology · doi:10.1016/s0065-2776(08)60756-7 · Cited by 291
Davidson, I., Xiao, J. H., Rosales, R., Staub, A., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90108-0 · Cited by 287
Zhu, Z., Tang, W., Ray, A., Wu, Y., Einarsson, O., Landry, M. L., Gwaltney, J., & Elias, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118431 · Cited by 282
Schlissel, M. S., Corcoran, L. M., & Baltimore, D. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.711 · Cited by 278
Self-citationBours, V, Burd, P. R., Brown, K., Villalobos, J., Park, S., Ryseck, R. P., Bravo, R., Kelly, K., & Siebenlist, U. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.685 · Cited by 269
Kitchens, R. L., Ulevitch, R. J., & Munford, R. S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.485 · Cited by 258
Protective effects of (−)-epigallocatechin-3-gallate on UVA- and UVB-induced skin damage
Kim, J., Hwang, J.-S., Cho, Y.-K., Han, Y., Jeon, Y.-J., & Yang, K.-H. (2001) · Skin Pharmacology and Physiology · doi:10.1159/000056329 · Cited by 134
DeLotto, R., DeLotto, Y., Steward, R., & Lippincott-Schwartz, J. (2007) · Development · doi:10.1242/dev.010934 · Cited by 82
Kang, J. S., Yoon, Y. D., Han, M. H., Han, S.-B., Lee, K., Kang, M. R., Moon, E.-Y., Jeon, Y. J., Park, S.-K., & Kim, H. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.009 · Cited by 43
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38
Metadata
- Authors
- Pierce, J. W., Lenardo, M., & Baltimore, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1988-03
- Volume
- 85
- Issue
- 5
- Pages
- 1482-1486
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2068584461
- Cited by
- 272
- References
- 27
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.